Navigation Links
Cervix Length at Mid-Pregnancy May Predict C-Section Risk
Date:3/26/2008

Finding won't change practice, but could help illuminate labor process, experts say,,,,

WEDNESDAY, March 26 (HealthDay News) -- The length of a woman's cervix at mid-pregnancy may indicate her risk of needing a Caesarean birth, a new study suggests.

"Women having their first baby who have a long cervix around 23 weeks of pregnancy are more likely to be delivered by emergency Caesarean section during labor at term," the study's lead author, Dr. Gordon Smith, head of obstetrics and gynecology at Cambridge University in the United Kingdom, said in a prepared statement.

"The nature of this finding is not such that women should now have this measurement performed to predict Caesarean section risk," he added. "The key issue in this analysis is understanding the processes that lead to normal and abnormal labor."

Several experts said that doctors won't be measuring your cervix halfway through your pregnancy to predict whether or not you'll have a natural birth any time soon.

"If the cervix hasn't prepped itself for labor, there's something going on," said Dr. Miriam Greene, an obstetrician at New York University Medical Center. "The idea that a longer cervix leads to a greater risk of Caesarean makes sense. The question is, if I start checking at 23 weeks and find a longer cervix, what then?"

Dr. Robert Lorenz, director of maternal-fetal medicine at Beaumont Hospital in Royal Oak, Mich., echoed Greene's sentiment. "This is a very interesting study that gives us another perspective on what happens in labor, but I don't think it has any immediate clinical applications," he said. Even years from now, he added, he's not sure anyone would intervene at 23 weeks, because "anything you do to change the cervix at 23 weeks might bring on preterm birth."

But both Greene and Lorenz said the new study was impressive because of the large numbers of women included, and because it adds to scientists
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
2. Free Drugs After Heart Attack Would Save Money, Lengthen Lives
3. Short Birth Length Boosts Mens Suicide Risk
4. The risk of osteoarthritis and index to ring finger length ratio
5. New UC Davis study finds physician style and HMO affiliation impact lengths of patient visit
6. Hilary Swank Donates Her Hair to Pantene(R) Beautiful Lengths(TM)
7. Radiation therapy technique reduces length of prostate cancer treatment
8. Radiation therapy technique reduces length of prostate cancer treatment
9. Vitamin D Supplements May Lengthen Life
10. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
11. MRI Can Be Predictor of Post-Treatment Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cervix Length at Mid-Pregnancy May Predict C-Section Risk
Cervix Length at Mid-Pregnancy May Predict C-Section Risk
(Date:5/20/2008)...e/ -- Ambulatory Services of,America, Inc. announc...h,joint venture to provide outpatient radiation on... between Denton Cancer Center, LP and ASA,s,subsid... ROSA of Denton,will own and operate a radiation t...ly owned and operated by Denton Cancer Center., (...
(Date:5/20/2008)...ng new out-patient procedures at no ... Calif., May 20 /PRNewswire/ -- Compass Clinical R... San Francisco Bay Area (RSC) are,hoping to recrui...nx, a,build-up of fluid in the fallopian tubes tha... as a part of a study of the effectiveness of a ne...
(Date:5/20/2008)...turated Fat - and with Omega-3, PARAMUS, N.J., Ma...(Nasdaq: SMBL ) has launched Smart Balance(R) But...utter Blend Sticks are 50 percent real butter,and ...art Balance(R) Butter,Blend Sticks are offered in ...or a healthier and tasty alternative for use in co...
(Date:5/20/2008)...ery or survival, researchers say. , , T...y dialysis for patients with acute kidney injury d...reduce the rate of organ failure, a new study find...n seen in critically ill patients. Approximately 2...d 35 percent of critically ill patients, will suff...
Breaking Medicine News(10 mins):Health News:Ambulatory Services of America, Inc. Announces Joint Venture With Denton Cancer Center, LP 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 2Health News:Research Grant to Fund Free Surgeries for Women Suffering From Blocked Fallopian Tubes 3Health News:New Smart Balance(R) Butter Blend Sticks Make Healthier Cooking & Baking Easy 2Health News:More Dialysis Not Better in Acute Kidney Injury 2
...es produced by the hypothalamus, the area of the b... and body temperature, may underlie chronic migrai... the general population who suffer from the debili... hormones could prevent or reduce the severity of ...
...inistration has approved a new drug for treating o...erioration in the cartilage of certain joints. Unl...toimmune disease, osteoarthritis results from over...of strenuous sports, obesity or aging. Pharmacia C...
...e Warren Grant Magnuson Clinical Center shows that...cook" tumors without actually removing them. The n...y and liver cancers, can also be used on cancers e... radiofrequency ablation (RFA), a tiny needle is i...
...ferred the launch of 'Disprin CV' (cardiovascular)...painkiller 'Disprin Plus', the company's Regional ... announced a change in the brand-name 'Disprin Plu...unch of Disprin Plus, there were reports citing in...
Other Medicine News:
(Date:5/19/2008)... May 19 /- Helix Health, the first U....ng a 90-minute webcast this,Wednesday, May 21, 200... Medicine Is Changing the Management of Breast & O...re, http://event.netbriefings.com/event/helixhealt... United States are diagnosed with cancer.,There is...
(Date:5/19/2008)...Be Presented at the 2008 Annual European Congress ...Against Rheumatism (EULAR) -, - Initiation of Pha... of 2008 -, SAN D...iences, Inc.,(Nasdaq: RDEA ) today announced the ...or the treatment of patients with gout, RDEA594. G...
(Date:5/19/2008)...egulatory equivalent filing anticipated in 1Q 2009.../ -- Pharmasset, Inc.,(Nasdaq: VRUS ) has nominat...e treatment of chronic hepatitis C virus (HCV). PS...rase inhibitor of HCV that is being advanced into,...dies required for,submission of an Investigational...
(Date:5/18/2008)...ve Disease Week data highlight effects of AMITIZA ...SAN DIEGO, May 18 /- New study result...ostone) 8 mcg lead to significant relief,of overal...pation (IBS-C).,These results were presented at Di...l international meeting of digestive disease speci...
Breaking Medicine Technology:Join NPR's David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 2Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 3Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 4Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594 5Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C 2Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C 3New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 2New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 3New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 4New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 5New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 6New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C) 7Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control 26 Sexual Function in Women 657 1Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control 26 Sexual Function in Women 657 2Research Study Demonstrates Prolonged Benefit of Fitness Program for Bladder Control 26 Sexual Function in Women 657 3Scientists discover tiny RNAs play a big role in controlling genes 4578 1Food restriction increases dopamine receptor levels in obese rats 4575 1Food restriction increases dopamine receptor levels in obese rats 4575 2Food restriction increases dopamine receptor levels in obese rats 4575 3The new source of islet cells 4571 1
...NCETON, N.J.--(BUSINESS WIRE)--Jun 28, 2007 - Cyto...ta from a Phase 1,dose escalation study evaluating...n) in combination with bortezomib (Velcade(R),Mil...lapsed,multiple myeloma. Data from 33 patients wer...al of Bortezomib (Vel) and Samarium,(Sam) in Multi...
..., Greece--(BUSINESS WIRE)--Jun 28, 2007 - ZIOPHARM...e presentation of two,posters at the XIth Annual I...reece from June 25-28th, 2007. The meeting highlig...atment of multiple,myeloma. ZIOPHARM is presenting...data that further elucidates its unique,mechanism ...
Other Medicine Technology:Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 2Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 3Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 4Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 5Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 6Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 7Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Quadramet at International Myeloma Workshop 8ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 2ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 3ZIO-101 (Darinaparsin) Interim Phase II and Preclinical Data,Presented at International Myeloma Workshop 4
...ists steerable guidewires across difficult lesions...eter offers a low profile (3F-4F) and is compatibl... crossing difficult occlusions. Once the occlusio...guidewire position and an angioplasty balloon is d...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system.
The new XVG catheter is our highest power thrombectomy catheter designed for accessing distal anatomy. Utilizing proprietary Cross-Stream water jet technology, the XVG catheter removes thrombus quick
...copic navigation system that tracks multiple intra...d Wittkampf, Ph.D., and is being developed by Surg...,The LocaLisa system uses three skin electrode p...art to track catheters. Using a reference electrod...
Medicine Products: